Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

The impact of morcellation on survival outcomes of undiagnosed uterine sarcoma.

Raspagliesi F, Bogani G, Lorusso D.

Gynecol Oncol Rep. 2018 Jan 28;23:37-38. doi: 10.1016/j.gore.2018.01.007. eCollection 2018 Feb. No abstract available.

2.

Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy.

Lorusso D, Tripodi E, Maltese G, Lepori S, Sabatucci I, Bogani G, Raspagliesi F.

Drug Des Devel Ther. 2018 May 29;12:1501-1509. doi: 10.2147/DDDT.S124447. eCollection 2018. Review.

3.

Potential impact of introducing a nonavalent HPV vaccination.

Bogani G, Taverna F, Lombardo C, Signorelli M, Chiappa V, Casarin J, Scaffa C, Leone Roberti Maggiore U, Recalcati D, Ditto A, Martinelli F, Borghi C, Perotto S, Ferrero S, Lorusso D, Raspagliesi F.

Int J Gynaecol Obstet. 2018 Jun 2. doi: 10.1002/ijgo.12546. [Epub ahead of print]

PMID:
29858884
4.

Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie-Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, Glenn McCluggage W, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Virchows Arch. 2018 Jun;472(6):937-938. doi: 10.1007/s00428-018-2380-7.

PMID:
29789924
5.

Role of bevacizumab in uterine leiomyosarcoma.

Bogani G, Ditto A, Martineli F, Signorelli M, Chiappa V, Fonatella C, Sanfilippo R, Leone Roberti Maggiore U, Ferrero S, Lorusso D, Raspagliesi F.

Crit Rev Oncol Hematol. 2018 Jun;126:45-51. doi: 10.1016/j.critrevonc.2018.03.019. Epub 2018 Mar 29. Review.

PMID:
29759566
6.

LASER treatment for women with high-grade vaginal intraepithelial neoplasia: A propensity-matched analysis on the efficacy of ablative versus excisional procedures.

Bogani G, Ditto A, Martinelli F, Mosca L, Chiappa V, Rossetti D, Leone Roberti Maggiore U, Sabatucci I, Lorusso D, Raspagliesi F.

Lasers Surg Med. 2018 May 14. doi: 10.1002/lsm.22941. [Epub ahead of print]

PMID:
29756652
7.

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Radiother Oncol. 2018 Apr 12. pii: S0167-8140(18)30135-X. doi: 10.1016/j.radonc.2018.03.003. [Epub ahead of print]

PMID:
29728273
8.

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie-Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Virchows Arch. 2018 Jun;472(6):919-936. doi: 10.1007/s00428-018-2362-9. Epub 2018 May 4. Erratum in: Virchows Arch. 2018 May 23;:.

PMID:
29725757
9.

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Int J Gynecol Cancer. 2018 May;28(4):641-655. doi: 10.1097/IGC.0000000000001216.

PMID:
29688967
10.

Factors Predictive of 90-Day Morbidity, Readmission, and Costs in Patients Undergoing Pelvic Exenteration.

Bogani G, Signorelli M, Ditto A, Martinelli F, Casarin J, Mosca L, Leone Roberti Maggiore U, Chiappa V, Lorusso D, Raspagliesi F.

Int J Gynecol Cancer. 2018 Jun;28(5):975-982. doi: 10.1097/IGC.0000000000001251.

PMID:
29683876
11.

Findings Linking Mismatch Repair Mutation With Age at Endometrial and Ovarian Cancer Onset in Lynch Syndrome.

Bogani G, Leone Roberti Maggiore U, Lorusso D, Raspagliesi F.

JAMA Oncol. 2018 Jun 1;4(6):889. doi: 10.1001/jamaoncol.2018.0253. No abstract available.

PMID:
29621388
12.

Ovarian preservation in locally advanced cervical cancer undergoing neoadjuvant chemotherapy and radical surgery: our experience and analysis of the literature.

Signorelli M, Bogani G, Chiappa V, Ditto A, Scaffa C, Martinelli F, Lorusso D, Raspagliesi F.

Minerva Ginecol. 2018 Mar 30. doi: 10.23736/S0026-4784.18.04221-1. [Epub ahead of print]

PMID:
29600835
13.

Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study.

Bergamini A, Ferrandina G, Candiani M, Cormio G, Giorda G, Lauria R, Perrone AM, Scarfone G, Breda E, Savarese A, Frigerio L, Gadducci A, Mascilini F, Maneschi F, Cassani C, Marchetti C, Cecere SC, Biglia N, De Giorgi U, Raspagliesi F, Lorusso D, Mangili G.

Eur J Surg Oncol. 2018 Jun;44(6):766-770. doi: 10.1016/j.ejso.2018.03.001. Epub 2018 Mar 10.

PMID:
29576462
14.

Oncologic effectiveness of nerve-sparing radical hysterectomy in cervical cancer.

Ditto A, Bogani G, Leone Roberti Maggiore U, Martinelli F, Chiappa V, Lopez C, Perotto S, Lorusso D, Raspagliesi F.

J Gynecol Oncol. 2018 May;29(3):e41. doi: 10.3802/jgo.2018.29.e41. Epub 2018 Feb 28.

15.

A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses.

Bogani G, Tagliabue E, Signorelli M, Ditto A, Martinelli F, Chiappa V, Mosca L, Sabatucci I, Leone Roberti Maggiore U, Lorusso D, Raspagliesi F.

J Gynecol Oncol. 2018 May;29(3):e40. doi: 10.3802/jgo.2018.29.e40. Epub 2018 Feb 23.

16.

Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer.

Piccirillo MC, Scambia G, Bologna A, Signoriello S, Vergote I, Baumann K, Lorusso D, Murgia V, Sorio R, Ferrandina G, Sacco C, Cormio G, Breda E, Cinieri S, Natale D, Mangili G, Pisano C, Cecere SC, Di Napoli M, Salutari V, Raspagliesi F, Arenare L, Bergamini A, Bryce J, Daniele G, Gallo C, Pignata S, Perrone F.

Ann Oncol. 2018 May 1;29(5):1189-1194. doi: 10.1093/annonc/mdy062.

PMID:
29462248
17.

The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment.

Bogani G, Leone Roberti Maggiore U, Signorelli M, Martinelli F, Ditto A, Sabatucci I, Mosca L, Lorusso D, Raspagliesi F.

Crit Rev Oncol Hematol. 2018 Feb;122:92-97. doi: 10.1016/j.critrevonc.2017.12.017. Epub 2017 Dec 28. Review.

PMID:
29458794
18.

Predicting Factors for High-Grade Cervical Dysplasia in Women With Low-Grade Cervical Cytology and Nonvisible Squamocolumnar Junction.

Bogani G, Taverna F, Lombardo C, Ditto A, Martinelli F, Signorelli M, Chiappa V, Leone Roberti Maggiore U, Mosca L, Sabatucci I, Scaffa C, Lorusso D, Raspagliesi F.

Reprod Sci. 2018 Jan 1:1933719118756747. doi: 10.1177/1933719118756747. [Epub ahead of print]

PMID:
29402202
19.

Artificial intelligence estimates the impact of human papillomavirus types in influencing the risk of cervical dysplasia recurrence: progress toward a more personalized approach.

Bogani G, Ditto A, Martinelli F, Signorelli M, Chiappa V, Leone Roberti Maggiore U, Taverna F, Lombardo C, Borghi C, Scaffa C, Lorusso D, Raspagliesi F.

Eur J Cancer Prev. 2018 Jan 22. doi: 10.1097/CEJ.0000000000000432. [Epub ahead of print]

PMID:
29360648
20.

Minimally Invasive Nerve-Sparing Radical Hysterectomy: A Win-Win Scenario.

Bogani G, Raspagliesi F.

J Invest Surg. 2018 Jan 16:1-2. doi: 10.1080/08941939.2017.1413149. [Epub ahead of print] No abstract available.

PMID:
29336619
21.

Nerve-Sparing Approach Improves Outcomes of Patients Undergoing Minimally Invasive Radical Hysterectomy: A Systematic Review and Meta-Analysis.

Bogani G, Rossetti DO, Ditto A, Signorelli M, Martinelli F, Mosca L, Scaffa C, Leone Roberti Maggiore U, Chiappa V, Sabatucci I, Lorusso D, Raspagliesi F.

J Minim Invasive Gynecol. 2018 Mar - Apr;25(3):402-410. doi: 10.1016/j.jmig.2017.11.014. Epub 2017 Dec 2. Review.

PMID:
29191471
22.

The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC-IV Unresectable Ovarian Cancer: Results From a Multi-Institutional Study.

Bogani G, Matteucci L, Tamberi S, Arcangeli V, Ditto A, Maltese G, Signorelli M, Martinelli F, Chiappa V, Leone Roberti Maggiore U, Perotto S, Scaffa C, Comerci G, Stefanetti M, Raspagliesi F, Lorusso D.

Int J Gynecol Cancer. 2017 Nov;27(9):1856-1862. doi: 10.1097/IGC.0000000000001108.

PMID:
29064913
23.

Invasive Paget Disease of the Vulva.

Borghi C, Bogani G, Ditto A, Martinelli F, Signorelli M, Chiappa V, Scaffa C, Perotto S, Leone Roberti Maggiore U, Recalcati D, Lorusso D, Raspagliesi F.

Int J Gynecol Cancer. 2018 Jan;28(1):176-182. doi: 10.1097/IGC.0000000000001131.

PMID:
28976448
24.

Introducing nerve-sparing approach during minimally invasive radical hysterectomy for locally-advanced cervical cancer: A multi-institutional experience.

Raspagliesi F, Bogani G, Spinillo A, Ditto A, Bogliolo S, Casarin J, Leone Roberti Maggiore U, Martinelli F, Signorelli M, Gardella B, Chiappa V, Scaffa C, Ferrero S, Cromi A, Lorusso D, Ghezzi F.

Eur J Surg Oncol. 2017 Nov;43(11):2150-2156. doi: 10.1016/j.ejso.2017.08.015. Epub 2017 Sep 7.

PMID:
28927778
25.

Atypical Uterine Smooth Muscle Tumors: A Retrospective Evaluation of Clinical and Pathologic Features.

Maltese G, Fontanella C, Lepori S, Scaffa C, Fucà G, Bogani G, Provenzano S, Carcangiu ML, Raspagliesi F, Lorusso D.

Oncology. 2018;94(1):1-6. doi: 10.1159/000479818. Epub 2017 Sep 5.

PMID:
28869928
26.

Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study.

Pignata S, Scambia G, Bologna A, Signoriello S, Vergote IB, Wagner U, Lorusso D, Murgia V, Sorio R, Ferrandina G, Sacco C, Cormio G, Breda E, Cinieri S, Natale D, Mangili G, Pisano C, Cecere SC, Di Napoli M, Salutari V, Raspagliesi F, Arenare L, Bergamini A, Bryce J, Daniele G, Piccirillo MC, Gallo C, Perrone F.

J Clin Oncol. 2017 Oct 10;35(29):3347-3353. doi: 10.1200/JCO.2017.73.4293. Epub 2017 Aug 21.

PMID:
28825853
27.

Implementation of Extensive Cytoreduction Resulted in Improved Survival Outcomes for Patients with Newly Diagnosed Advanced-Stage Ovarian, Tubal, and Peritoneal Cancers.

Raspagliesi F, Bogani G, Ditto A, Martinelli F, Chiappa V, Borghi C, Scaffa C, Morano F, Maltese G, Lorusso D.

Ann Surg Oncol. 2017 Oct;24(11):3396-3405. doi: 10.1245/s10434-017-6030-0. Epub 2017 Aug 9.

PMID:
28795373
28.

Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein.

Erba E, Romano M, Gobbi M, Zucchetti M, Ferrari M, Matteo C, Panini N, Colmegna B, Caratti G, Porcu L, Fruscio R, Perlangeli MV, Mezzanzanica D, Lorusso D, Raspagliesi F, D'Incalci M.

Biochem Pharmacol. 2017 Nov 15;144:52-62. doi: 10.1016/j.bcp.2017.08.001. Epub 2017 Aug 4.

PMID:
28782526
29.

Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses.

Bogani G, Tagliabue E, Ditto A, Signorelli M, Martinelli F, Casarin J, Chiappa V, Dondi G, Leone Roberti Maggiore U, Scaffa C, Borghi C, Montanelli L, Lorusso D, Raspagliesi F.

Gynecol Oncol. 2017 Oct;147(1):61-65. doi: 10.1016/j.ygyno.2017.07.139. Epub 2017 Aug 2.

PMID:
28779965
30.

Laparoscopy Compared With Laparotomy for Debulking Ovarian Cancer After Neoadjuvant Chemotherapy.

Martinelli F, Ditto A, Bogani G, Raspagliesi F.

Obstet Gynecol. 2017 Aug;130(2):469-470. doi: 10.1097/AOG.0000000000002183. No abstract available.

PMID:
28742659
31.

Pharmacokinetic drug evaluation of pazopanib for the treatment of uterine leiomyosarcomas.

Ferrero S, Leone Roberti Maggiore U, Aiello N, Barra F, Ditto A, Bogani G, Raspagliesi F, Lorusso D.

Expert Opin Drug Metab Toxicol. 2017 Aug;13(8):881-889. doi: 10.1080/17425255.2017.1351943. Epub 2017 Jul 13. Review.

PMID:
28678537
32.

Safety and effectiveness of Human Papillomavirus (HPV) vaccination: NCI of Milan position statement.

Bogani G, Lorusso D, Raspagliesi F.

Vaccine. 2017 Sep 18;35(39):5227. doi: 10.1016/j.vaccine.2017.06.068. Epub 2017 Jun 29. No abstract available.

PMID:
28669614
33.

Regarding "The Role of Routine Peritoneal and Omental Biopsies at Risk-reducing Salpingo-oophorectomy".

Bogani G, Signorelli M, Chiappa V, Carcangiu ML, Martinelli F, Paolini B, Leone Roberti Maggiore U, Gennaro M, Borghi C, Scaffa C, Ditto A, Lorusso D, Raspagliesi F.

J Minim Invasive Gynecol. 2017 Nov - Dec;24(7):1243-1244. doi: 10.1016/j.jmig.2017.05.020. Epub 2017 Jun 23. No abstract available.

PMID:
28648838
34.

Treatment of Genital Melanoma: Are We Ready for Innovative Therapies?

Ditto A, Bogani G, Martinelli F, Raspagliesi F.

Int J Gynecol Cancer. 2017 Jul;27(6):1063. doi: 10.1097/IGC.0000000000001018. No abstract available.

PMID:
28640175
35.

Sentinel node mapping in endometrial cancer following Hysteroscopic injection of tracers: A single center evaluation over 200 cases.

Martinelli F, Ditto A, Signorelli M, Bogani G, Chiappa V, Lorusso D, Scaffa C, Recalcati D, Perotto S, Haeusler E, Raspagliesi F.

Gynecol Oncol. 2017 Sep;146(3):525-530. doi: 10.1016/j.ygyno.2017.06.014. Epub 2017 Jul 5.

PMID:
28625394
36.

Sentinel-lymph-node mapping in endometrial cancer.

Bogani G, Ditto A, Leone Roberti Maggiore U, Lorusso D, Raspagliesi F.

Lancet Oncol. 2017 May;18(5):e234. doi: 10.1016/S1470-2045(17)30247-4. No abstract available.

PMID:
28495280
37.

Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience.

Bogani G, Tagliabue E, Signorelli M, Chiappa V, Carcangiu ML, Paolini B, Casarin J, Scaffa C, Gennaro M, Martinelli F, Borghi C, Ditto A, Lorusso D, Raspagliesi F.

J Minim Invasive Gynecol. 2017 Jul - Aug;24(5):837-842. doi: 10.1016/j.jmig.2017.04.017. Epub 2017 May 4.

PMID:
28479170
38.

The safety of antiangiogenic agents and PARP inhibitors in platinum-sensitive recurrent ovarian cancer.

Lorusso D, Fontanella C, Maltese G, Lepori S, Tripodi E, Bogani G, Raspagliesi F.

Expert Opin Drug Saf. 2017 Jun;16(6):687-696. doi: 10.1080/14740338.2017.1325871. Epub 2017 May 18. Review.

PMID:
28471247
39.

Involvement of AF1q/MLLT11 in the progression of ovarian cancer.

Tiberio P, Lozneanu L, Angeloni V, Cavadini E, Pinciroli P, Callari M, Carcangiu ML, Lorusso D, Raspagliesi F, Pala V, Daidone MG, Appierto V.

Oncotarget. 2017 Apr 4;8(14):23246-23264. doi: 10.18632/oncotarget.15574.

40.

Retrospective study of the influence of HPV persistence on outcomes among women with high-risk HPV infections and negative cytology.

Bogani G, Taverna F, Lombardo C, Borghi C, Martinelli F, Signorelli M, Leone Roberti Maggiore U, Chiappa V, Scaffa C, Ditto A, Lorusso D, Raspagliesi F.

Int J Gynaecol Obstet. 2017 Jul;138(1):62-68. doi: 10.1002/ijgo.12170. Epub 2017 Apr 27.

PMID:
28388819
41.

Impact of Surgical Route in Influencing the Risk of Lymphatic Complications After Ovarian Cancer Staging.

Bogani G, Borghi C, Ditto A, Signorelli M, Martinelli F, Chiappa V, Scaffa C, Perotto S, Leone Roberti Maggiore U, Montanelli L, Di Donato V, Infantino C, Lorusso D, Raspagliesi F.

J Minim Invasive Gynecol. 2017 Jul - Aug;24(5):739-746. doi: 10.1016/j.jmig.2017.03.014. Epub 2017 Mar 24. Review.

PMID:
28347880
42.

Impact of Morcellation of Occult Malignancies at the Time of Vaginal Hysterectomy.

Bogani G, Signorelli M, Chiappa V, Lorusso D, Raspagliesi F.

J Minim Invasive Gynecol. 2017 Jul - Aug;24(5):876-877. doi: 10.1016/j.jmig.2017.03.005. Epub 2017 Mar 14. No abstract available.

PMID:
28302558
43.

Investigational drugs for the treatment of cervical cancer.

Barra F, Lorusso D, Leone Roberti Maggiore U, Ditto A, Bogani G, Raspagliesi F, Ferrero S.

Expert Opin Investig Drugs. 2017 Apr;26(4):389-402. doi: 10.1080/13543784.2017.1302427. Epub 2017 Mar 8. Review.

PMID:
28274154
44.

Accuracy of pre-operative hysteroscopic guided biopsy for predicting final pathology in uterine malignancies.

Martinelli F, Ditto A, Bogani G, Signorelli M, Chiappa V, Lorusso D, Haeusler E, Raspagliesi F.

J Cancer Res Clin Oncol. 2017 Jul;143(7):1275-1279. doi: 10.1007/s00432-017-2371-0. Epub 2017 Mar 1.

PMID:
28247037
45.

Minimally Invasive Surgical Staging in Early-stage Ovarian Carcinoma: A Systematic Review and Meta-analysis.

Bogani G, Borghi C, Leone Roberti Maggiore U, Ditto A, Signorelli M, Martinelli F, Chiappa V, Lopez C, Sabatucci I, Scaffa C, Indini A, Ferrero S, Lorusso D, Raspagliesi F.

J Minim Invasive Gynecol. 2017 May - Jun;24(4):552-562. doi: 10.1016/j.jmig.2017.02.013. Epub 2017 Feb 20. Review.

PMID:
28223182
46.

The association of pre-treatment HPV subtypes with recurrence of VIN.

Bogani G, Martinelli F, Ditto A, Signorelli M, Taverna F, Lombardo C, Chiappa V, Leone Roberti Maggiore U, Recalcati D, Scaffa C, Perotto S, Sabatucci I, Indini A, Lorusso D, Raspagliesi F.

Eur J Obstet Gynecol Reprod Biol. 2017 Apr;211:37-41. doi: 10.1016/j.ejogrb.2017.01.057. Epub 2017 Feb 1.

PMID:
28178576
47.

Impact of Blood Transfusions on Survival of Locally Advanced Cervical Cancer Patients Undergoing Neoadjuvant Chemotherapy Plus Radical Surgery.

Bogani G, Ditto A, Martinelli F, Signorelli M, Chiappa V, Lopez C, Indini A, Leone Roberti Maggiore U, Sabatucci I, Lorusso D, Raspagliesi F.

Int J Gynecol Cancer. 2017 Mar;27(3):514-522. doi: 10.1097/IGC.0000000000000902.

PMID:
28129238
48.

Emesis and nausea related to single agent trabectedin in ovarian cancer patients: a sub-study of the MITO15 project.

Di Napoli M, Della Pepa C, Arenare L, Scambia G, Lorusso D, Raspagliesi F, Ferrandina G, Salutari V, Sorio R, Mosconi AM, Mangili G, Borgato L, Lepori S, Salvino A, Pignata S, Cecere SC.

Support Care Cancer. 2017 Jun;25(6):1743-1748. doi: 10.1007/s00520-016-3547-x. Epub 2017 Jan 19.

PMID:
28101677
49.

Human papillomavirus (HPV) persistence and HPV 31 predict the risk of recurrence in high-grade vaginal intraepithelial neoplasia.

Bogani G, Martinelli F, Ditto A, Taverna F, Lombardo C, Signorelli M, Chiappa V, Leone Roberti Maggiore U, Fontanella C, Sabatucci I, Borghi C, Recalcati D, Indini A, Lorusso D, Raspagliesi F.

Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:157-165. doi: 10.1016/j.ejogrb.2016.12.020. Epub 2016 Dec 23.

PMID:
28039759
50.

Tertiary cytoreduction for recurrent endometrial cancer.

Bellati F, Papadia A, Gasparri ML, Scanagatta P, Carriero F, Beneditti Panici P, Raspagliesi F.

Eur J Gynaecol Oncol. 2017;38(1):132-134.

PMID:
29767882

Supplemental Content

Loading ...
Support Center